Connect with us
New agreement to fund Phase II trials for cannabis glaucoma treatment New agreement to fund Phase II trials for cannabis glaucoma treatment

Medicinal

New agreement to fund Phase II trials for cannabis glaucoma treatment

Emerald Health Therapeutics has signed an agreement with Skye Bioscience.

Sign up for the Cannabis Wealth newsletter

Recent Posts